Trial Details
COMPLETEDBasic Information
| Clinical ID | c1809 |
|---|---|
| Identifier | NCT01476995 |
| Trial Title | Prognostic Indicators as Provided by the EPIC ClearView |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Coronary Artery Disease|Congestive Heart Failure|Valvular Heart Disease|Atrial Fibrillation|Hypertension|Pyelonephritis|Acute Renal Failure|Renal Failure|Viral Hepatitis|Alcoholic Hepatitis|Steatohepatitis|Cirrhosis|Asthma|COPD|Bronchitis|Emphysema|Pneumonia|Inflammatory Bowel Disease|Crohn's Disease|Ulcerative Colitis|Diverticulitis|Peptic Ulcer Disease|Irritable Bowel Syndrome|Cholecystitis|Pancreatitis|Malabsorption Disorders|Celiac Sprue|Diabetes |
| Interventions | - |
Participant Information
| Sponsor | Epic Research & Diagnostics, Inc. |
|---|---|
| City | Baltimore |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2025-09-10 |
|---|---|
| Primary Completion Date | 2025-06-11 |
| Completion Date | 2025-06-11 |